EW vs GRDN · P/E 47, rev $1.39B vs rev $377.4M
Edwards Lifesciences Corp (EW) versus Guardian Pharmacy Services, Inc. (GRDN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Guardian Pharmacy Services, Inc. (GRDN) is a medical care facilities company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported GRDN revenue for 2025-09-30 was $377.4M. Net income was $9.6M. Revenue was up 9.6% from 2025-06-30 to 2025-09-30. GRDN currently screens at market cap $1.25B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. GRDN currently screens at market cap $1.25B.
Not investment advice. Open the EW and GRDN stock pages for the full models.
Not investment advice.